Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Hepatic Impairment

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516292-33-00

Acronym

ASTX727-18

Enrollment

Registered

2024-08-29

Start date

2021-10-22

Completion date

Unknown

Last updated

2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid lymphoma (AML), Myelodysplastic syndrome (MDS), Solid tumor

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, Poland, Romania, Slovakia, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026